These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26068040)

  • 1. The effects of chemically synthesized saposin C on glucosylceramide-β-glucosidase.
    Yoneshige A; Muto M; Watanabe T; Hojo H; Matsuda J
    Clin Biochem; 2015 Nov; 48(16-17):1177-80. PubMed ID: 26068040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N370S (Asn370-->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C.
    Salvioli R; Tatti M; Scarpa S; Moavero SM; Ciaffoni F; Felicetti F; Kaneski CR; Brady RO; Vaccaro AM
    Biochem J; 2005 Aug; 390(Pt 1):95-103. PubMed ID: 15826241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of glucocerebrosidase dimer in solution by its co-factor, saposin C.
    Gruschus JM; Jiang Z; Yap TL; Hill SA; Grishaev A; Piszczek G; Sidransky E; Lee JC
    Biochem Biophys Res Commun; 2015 Feb; 457(4):561-6. PubMed ID: 25600808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.
    Vaccaro AM; Motta M; Tatti M; Scarpa S; Masuelli L; Bhat M; Vanier MT; Tylki-Szymanska A; Salvioli R
    Hum Mol Genet; 2010 Aug; 19(15):2987-97. PubMed ID: 20484222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in Sap C-deficient fibroblasts.
    Tatti M; Motta M; Di Bartolomeo S; Scarpa S; Cianfanelli V; Cecconi F; Salvioli R
    Hum Mol Genet; 2012 Dec; 21(23):5159-73. PubMed ID: 22949512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucosylceramidase mass and subcellular localization are modulated by cholesterol in Niemann-Pick disease type C.
    Salvioli R; Scarpa S; Ciaffoni F; Tatti M; Ramoni C; Vanier MT; Vaccaro AM
    J Biol Chem; 2004 Apr; 279(17):17674-80. PubMed ID: 14757764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid beta-glucosidase: intrinsic fluorescence and conformational changes induced by phospholipids and saposin C.
    Qi X; Grabowski GA
    Biochemistry; 1998 Aug; 37(33):11544-54. PubMed ID: 9708990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.
    Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Barca A; Scerch C
    J Biol Chem; 1997 Jul; 272(27):16862-7. PubMed ID: 9201993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease.
    Van Patten SM; Hughes H; Huff MR; Piepenhagen PA; Waire J; Qiu H; Ganesa C; Reczek D; Ward PV; Kutzko JP; Edmunds T
    Glycobiology; 2007 May; 17(5):467-78. PubMed ID: 17251309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation.
    Sun Y; Qi X; Grabowski GA
    J Biol Chem; 2003 Aug; 278(34):31918-23. PubMed ID: 12813057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation).
    Zimmer KP; le Coutre P; Aerts HM; Harzer K; Fukuda M; O'Brien JS; Naim HY
    J Pathol; 1999 Aug; 188(4):407-14. PubMed ID: 10440752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human acid beta-glucosidase. Use of inhibitory and activating monoclonal antibodies to investigate the enzyme's catalytic mechanism and saposin A and C binding sites.
    Fabbro D; Grabowski GA
    J Biol Chem; 1991 Aug; 266(23):15021-7. PubMed ID: 1714449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype.
    Liou B; Zhang W; Fannin V; Quinn B; Ran H; Xu K; Setchell KDR; Witte D; Grabowski GA; Sun Y
    Sci Rep; 2019 Apr; 9(1):5571. PubMed ID: 30944381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins.
    Motta M; Camerini S; Tatti M; Casella M; Torreri P; Crescenzi M; Tartaglia M; Salvioli R
    Hum Mol Genet; 2014 Nov; 23(21):5814-26. PubMed ID: 24925315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
    Sun Y; Liou B; Chu Z; Fannin V; Blackwood R; Peng Y; Grabowski GA; Davis HW; Qi X
    EBioMedicine; 2020 May; 55():102735. PubMed ID: 32279952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate-containing membranes: patient variant Saposin A lacks lipid extraction capacity.
    Locatelli-Hoops S; Remmel N; Klingenstein R; Breiden B; Rossocha M; Schoeniger M; Koenigs C; Saenger W; Sandhoff K
    J Biol Chem; 2006 Oct; 281(43):32451-60. PubMed ID: 16905746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
    Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
    Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient one-step chromatographic purification and functional characterization of recombinant human Saposin C.
    Motta M; Tatti M; Martinelli S; Camerini S; Scarpa S; Crescenzi M; Tartaglia M; Salvioli R
    Protein Expr Purif; 2011 Aug; 78(2):209-15. PubMed ID: 21463688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.
    Sun Y; Ran H; Zamzow M; Kitatani K; Skelton MR; Williams MT; Vorhees CV; Witte DP; Hannun YA; Grabowski GA
    Hum Mol Genet; 2010 Feb; 19(4):634-47. PubMed ID: 20015957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.
    Wilkening G; Linke T; Sandhoff K
    J Biol Chem; 1998 Nov; 273(46):30271-8. PubMed ID: 9804787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.